Twist Bioscience CEO Emily M. Leproust disposes of USD 51.47 million in common shares
TWST•CEO sells shares after exercising options
Twist Bioscience CEO Emily M. Leproust exercised employee stock options for 208,708 shares on Sept. 17, 2026.
She sold 356,546 shares the same day at weighted average prices ranging from $151.46 to $163.39.
Her direct holding fell to 620,589 shares following the transactions.
Related News
High Roller Technologies director Daniel Waldemar Bradtke sells USD 30,800 common shares
ROLR•
US Cash Crude-Grades fall on hopes of supply disruptions in the Middle East easing
XLE•
